2022 top 100 future medical companies From Arterial network
The following is the 2022 top 100 future medical companies From Arterial network recommended by recordtrend.com. And this article belongs to the classification: Medical health.
If the next 10 years will be a golden age for the development of the medical and health industry, it will be a journey full of stories. These stories are happening and spreading in the hot land of innovation in China. We are witnessing a group of technology maniacs and medical geniuses changing the world of life science.
In the sixth year of the top 100, we took the “China story” as the basic perspective, took the local innovation that took place in China and the new solutions that Chinese local innovation brought to the world’s problems as the narrative context, and passed on the stories belonging to China’s life science industry through the narration of Chinese story heroes. Based on this, the cloud summit meeting of the sixth top 100 future medical conferences in 2022 officially opened on June 14. Through 5 days of meetings, 22 theme forums and 78 hours of speeches and dialogues, the cloud shared the story of medical health in China.
In addition to the wonderful sharing in various forums, there is also the selection of the future medical top 100 during the annual future medical top 100 conference. The selection of this list was launched in December 2021. During the collection period of more than four months, the Organizing Committee of the list recovered nearly 1300 application materials of enterprises through independent declaration, institutional recommendation, targeted research and other means. Each review of the application materials is a reading of the Chinese story. In this process, we are also lucky to see the medical innovation spirit behind the Chinese story described by the medical and health innovators.
Take questions and find answers. We believe that this is the bottom color of the medical and health China story and the premise to face unlimited challenges with limited energy. How to promote drug R & D and technological innovation to solve the unmet clinical needs? From these 1300 materials, we can see the answer. 30+ AI drug R & D related enterprises are exploring the infinite possibilities of AI pharmaceutical in target identification, compound screening, real world research, drug clinical trials and other directions through algorithm platform and self-development pipeline; 20+ brain science related enterprises are providing new ideas for brain disease diagnosis and treatment through brain computer interface, digital therapy, EEG big data and other channels.
Infinite curiosity and endurance. In the application materials of entrepreneurs and scientists, we have seen the words “breakthrough”, “first time”, “focus” and other words used to describe the innovative power of characters, as well as the R & D achievements and business achievements behind them. By maintaining infinite curiosity, innovative entrepreneurs can lead their teams to maintain love and focus in the back and forth boring R & D process and business model revision process, which is the source power for the enterprise to continue to move forward; Perseverance helps scientists to go through the silent night waiting for the experimental results, the source innovation can be from 0 to 1, and the experimental samples can be commercialized. Maintaining infinite curiosity and endurance is the emotional color in the story of medical health China.
Catch up and surpass. From sprouting to catching up, from following to leading, this is the momentum of China’s local innovation we see, and it is also the narrative direction of the Chinese story of the medical and health industry. In the enterprise application materials, 70% of the enterprises systematically sorted out and stated the core value, cost-benefit, compliance, iterative innovation, strategic planning, etc. around their core products under research. We were pleasantly surprised to see that under the background of domestic substitution of medical devices, a large number of innovative products with international competitiveness appeared in the golden circuit; The R & D capability of local pharmaceutical enterprises is becoming more and more mature, and they have formulated sea going strategies and action plans according to their own actual situation. Transcending and catching up, the world is looking at the identity and contribution of China’s explosive innovation in international innovation from a new perspective.
Don’t stop chasing the wind and the moon. Pay tribute to all the innovations and stories that have taken place in China.
List release
Founded in 2015, the top 100 list of the future medical industry is the first list of innovative medical fields for non listed enterprises in China launched by VB100, arterial network and eggshell Research Institute. It aims to select Chinese innovative medical practitioners who truly represent the future medical industry, discover the core power of China’s future medical industry, and promote the innovation and reform process of the health care industry. Over the past seven years, the list system of the top 100 medical companies in the future has been continuously enriched, and a global list of innovative medical health ecology for enterprises, investment institutions, hospitals and industrial parks has been gradually formed. It is the annual selection in the field of life health that is most concerned by the industry and capital circles.
In addition, aoji.com will launch the growth report of the top 100 enterprises according to the list of the top 100 medical enterprises in the future every year. When the list of the top 100 future medical enterprises in 2022 was released, the growth analysis report of the top 100 future medical enterprises in 2022 was launched again to comprehensively analyze the relevant data of the four major enterprises in the list of China’s innovative medical services, China’s innovative medical devices, China’s innovative digital medicine and China’s innovative biomedicine. We hope that with the help of the analysis of the top 100 medical enterprises in the future, we can summarize the growth law and industrial change trend of enterprises, and provide reference for medical and health enterprises and entrepreneurs. (an excerpt of the report is provided in the following text, and the way to obtain the report is provided at the end of the text.)
The 2022 list of the top 100 future medical enterprises series includes the top 100 future medical enterprises · main list, the top 100 future medical enterprises · value field list, the top 100 future medical enterprises · innovation power list, and the top 100 future medical enterprises · Pengcheng award and Weilan award.
Main list
This selection is for non listed enterprises in the medical and health field. Based on the VB100 value evaluation model, through the process of enterprise independent declaration, VB100 review meeting review, supporting organization cross review and expert committee final review, the top 100 innovative enterprises are selected from four major fields (medical services / digital medicine / medical devices / biomedicine). In addition to the valuation, we will focus on the growth and annual performance of the candidate enterprises in the four primary indicators of human resources, knowledge resources, important partner resources and market performance, including a total of 17 secondary indicators.
List of value areas
Every year, through multi-directional and all-round insight and exploration such as investor interview, reporter interview and Industry Report study, the selection takes the capital attention as the benchmark, supplemented by three aspects of media focus, annual performance data heat of medical and health enterprises, and future development prosperity of the medical and health industry, to make an inventory of 60+ sub sectors of the four major racetracks: medical devices, biomedicine, digital medicine, and medical services, Select the top ten value fields of the year, and select the most representative and growing innovative enterprises in each value field.
Ranking list of innovation power of Listed Enterprises
As the backbone of China’s economic development, the innovation power of listed companies is not only the core engine of enterprise development, but also has important practical significance for national innovation strategy and industrial upgrading. Based on the annual report data of listed enterprises in 2021, this selection is made by supplementing and investigating more than 30 relevant index data of listed enterprises in the four dimensions of innovation input, innovation output, innovation benefit and innovation activities, and combining the evaluation method of arterial network for the analysis of innovation trend and space of the track where the listed enterprises are located.
Pengcheng Award
“Pengcheng orange” means a bright future. The exclusive color of the award is orange. Orange is the main color of egg yolk technology. It is a symbol of prosperity, strength, wisdom and vitality. It represents the style and posture of the participants in the medical and health field who are striving for innovation. The future medical top 100 · Pengcheng award will select the investment institutions, enterprises and parks in the medical and health field, focusing on the annual performance and breakthroughs of the candidate units during the evaluation period.
More lists: arterial network
More reading: arterial network & eggshell Research Institute: 2021 Internet hospital report (download attached) Arterial network: analysis of the big health industry fund of listed companies arterial network: the top ten most powerful investment institutions in the medical and health field in 2016 arterial network: the annual inventory of the maternal and child industry in 2016 arterial network: the list of Internet Medical deaths in 2016 arterial network: the prediction of the eight trends in medical and health in 2017 arterial network: the total overseas investment of Chinese medical enterprises has exceeded US $5.8 billion since 2016 arterial network: the Research Report on assisted reproduction industry in 2018 (attached) PricewaterhouseCoopers & arterial network: the road to digital transformation of China’s health industry arterial network: report on the development status of private hospitals (attached with download) arterial network & eggshell Research Institute: Q3 global health industry capital report in 2020 (attached with download) arterial network: medical health industry investment and financing report in the first half of 2019 (attached with download) fruit doctor & arterial network: report on the development of high-end medical market under the background of consumption upgrading (attached with download) Arterial network: Q3 2018 investment and financing report of the medical and health industry (download attached) arterial network: in the first half of 2019, 10 medical and health enterprises went to Hong Kong for IPO, cornerstone pharmaceutical and Jinxin had high reproductive enthusiasm, and vaccine stocks led the stock price
If you want to get the full report, you can contact us by leaving us the comment. If you think the information here might be helpful to others, please actively share it. If you want others to see your attitude towards this report, please actively comment and discuss it. Please stay tuned to us, we will keep updating as much as possible to record future development trends.
RecordTrend.com is a website that focuses on future technologies, markets and user trends. We are responsible for collecting the latest research data, authority data, industry research and analysis reports. We are committed to becoming a data and report sharing platform for professionals and decision makers. We look forward to working with you to record the development trends of today’s economy, technology, industrial chain and business model.Welcome to follow, comment and bookmark us, and hope to share the future with you, and look forward to your success with our help.
